Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 105,398 | 129,503 | 99,219 | 81,504 | 65,846 |
| Cost of Goods | 9,784 | 11,688 | 8,685 | 7,492 | 8,830 |
| Gross Profit | 95,614 | 117,815 | 90,534 | 74,012 | 57,016 |
| Operating Expenses | 105,487 | 100,116 | 82,693 | 89,115 | 82,375 |
| Operating Income | -9,089 | 18,387 | 8,526 | -14,611 | -24,529 |
| Interest Expense | 4,368 | 3,001 | 3,071 | 3,029 | 2,982 |
| Other Income | 2,255 | 2,479 | 2,035 | 2,096 | 2,730 |
| Pre-tax Income | -11,202 | 17,865 | 7,490 | -15,544 | -24,781 |
| Income Tax | 93 | 470 | 80 | 342 | 279 |
| Net Income Continuous | -11,295 | 17,395 | 7,410 | -15,886 | -25,060 |
| Net Income | $-11,295 | $17,395 | $7,410 | $-15,886 | $-25,060 |
| EPS Basic Total Ops | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 |
| EPS Basic Continuous Ops | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 |
| EPS Diluted Total Ops | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 |
| EPS Diluted Continuous Ops | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.09 | 0.13 | 0.06 | -0.13 | -0.20 |
| EBITDA(a) | $-8,709 | $18,961 | $8,537 | $-14,743 | $-22,409 |